Pharm - Antidepressants Flashcards

(55 cards)

1
Q

describe the symptoms of withdrawal syndrome

A

FINISH

  • F: flu-like sx
  • I: insomnia
  • N: nausea
  • I: imbalance
  • S: sensory disturbances
  • H: hyperarousal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

in addition to major depressive disorder, Buproprion can be used for _______

A

nicotine withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

in addition to major depressive disorder, Imipramine can be used for _______

A

enuresis (repeated inability to control urination)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

in addition to major depressive disorder, Duloxetine can be used for _______

A
  • diabetic peripheral neuropathy
  • fibromyalgia
  • chronic MSK pain
  • stress incontinence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

list the SNRIs

A

(TDDVL)

  • TCAs
  • desvenlafaxine
  • duloxetine
  • venlafaxine
  • levomilnacipran
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

list the SSRIs

A

CFSEPVV

  • citalopram
  • fluoxetine
  • sertraline
  • escitalopram
  • paroxetine
  • vilazodone
  • vortioxetine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

list the NDRIs

A

bupropion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

list the SARAs

A

MNT

  • mirtazapine
  • nefazodone
  • trazodone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

list the MAOIs

A

TIPS

  • tranylcypromine
  • isocarboxazid
  • phenelzine
  • selegiline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

list the SNRI that also affects dopamine receptors

A

amoxapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MOA SARAs

A

serotonin-adrenergic receptor antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MOA vilazodone

A

serotonin-selective reuptake inhibitor

- ALSO partial agonist on 5-HT-1A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MOA vortioxetine

A

serotonin-selective reuptake inhibitor

ALSO:

  • partial agonist on 5-HT-1B
  • full agonist on 5-HT-1A
  • full antagonist on 5-HT-1D,3,7
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MOA bupropion

A

NDRI (noradrenergic-dopamine reuptake inhibitor)

ALSO:
- shown to increase NE/DA presynaptic release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

why do SSRIs have less side effects and risks compared to TCAs

A

less impact on histamine, muscarinic, and adrenergic receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

“normal” side effects of SSRIs

A
  • CNS: sedation, insomnia, agitation, nervousness
  • sexual dysfunction
  • weight gain
  • acute withdrawal reactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

rare, dose-dependent, toxic setting side effects of SSRIs

A
  • QT prolongation
  • hyponatremia
  • serotonin syndrome
  • suicidality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

describe sx of serotonin syndrome

A
  • sweating
  • hyperreflexia
  • akathisia/myoclonus
  • shivering/tremors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

compare the different SSRIs in terms of their likelihood of drug-drug interactions

A

most likely: fluoxetine

low/milk: citalopram, sertraline, vilazodone

least: vortioxetine and escitalopram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

compare tertiary amine TCAs and secondary amine TCAs to the other SNRIs

A

tertiary: inhibits both NE and 5-HT equally
secondary: inhibits NE more than 5-HT

other SNRIs: inhibit 5-HT more than NE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what are the 3 key TCA system-based side effects

A

1) cardiovascular (from alpha receptor antagonism)
- tachy, orthostatic hypotension, dysrhythmias

2) anticholinergic
- dry mouth, urinary retention, constipation, blurred vision

3) CNS (from histamine receptor antagonism)
- sedation, fatigue, dizziness, seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what are the 3 C’s of TCA toxic ingestion

A
  • coma
  • cardiotoxicity
  • convulsions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

compare SNRIs’ side effects to SSRIs’

A

SNRIs have similar side effects with less risk for sexual dysfunction

24
Q

MOA trazodone and nefazodone

A

SARAs

  • selectively block POST-synaptic ALPHA 1 receptors on NE neurons
  • selectively block POST-synaptic 5-HT-2 receptors
25
MOA mirtazapine
SARA - blocks PRE-synaptic ALPHA 2 receptors on NE and 5-HT neurons - blocks POST-synaptic 5-HT- 2/3 receptors
26
side effects of SARAs
- CNS: sedation - orthostatic hypotension - weight gain
27
side effects NDRIs
- agitation, insomnia - HTN, tachy, tremors - weight LOSS - seizures
28
which MAOIs are non-selective and which are selective
- selegiline is B-selective | - all others are non-selective (A/B)
29
what is the anti-depressant form of selegiline
a patch
30
side effects MAOIs
- orthostatic hypotension - sexual dysfunction - weight gain - insomnia/agitation/nervousness
31
drug interactions with MAOIs
- anti-hypertensives, amphetamines, SSRIs/TCAs/SNRIs **there must be a 2 week wash-out period from an SSRI before starting an MAOI**
32
what is the major concern of using MAOIs
hypertensive crisis
33
how do MAOIs cause hypertensive crisis what MAOI should you use for the lowest risk
non-selective MAOIs inhibit MAO-A necessary in GI for tyramine metabolism --> increased tyramine --> significant catecholamine release --> hypertensive crisis lowest risk: low-dose selegiline patch
34
signs/sx of hypertensive crisis | can be seen with MAOI use
- severe HA - N/V - sweating/severe anxiety - nosebleeds - tachy - CP - vision changes - SOB - confusion
35
MOA esketamine
NMDA-receptor antagonist
36
indications for esketamine
treatment-resistant depression in conjunction with ongoing antidepressant therapy
37
administration and observation for esketamine
administration: nasal observation: for 2 hours post-dose
38
MOA brexanolone
GABA-A receptor positive allosteric modulator
39
indications for brexanolone
post-partum depression
40
administration, observation, and efficacy of brexanolone
administration: 60 hour IV administration observation: every 2 hours for somnolence and LOC efficacy: superior efficacy to placebo at 60 hours (1 dose) and lasts up to 30 days
41
list the 3 anti-seizure meds
- carbamazepine - lamotrigine - divalproex/valproic acid
42
lithium's effect on doapmine neurotransmission
interferes with both stimulatory and inhibitory G proteins to keep them in inactive state
43
lithium's effect on NMDA receptor
downregulates the NMDA receptor
44
effect of lithium on GABA neurotransmission
lithium promotes GABAergic neurotransmission - increases GABA in CSF - presynaptically facilitates GABA release - postsynaptically upregulates GABA-B receptors
45
effect of lithium on phosphoinositide cycle
inhibits IPPase and IMPase
46
effect of lithium on PKC, MARCKS, and GSK-3
inhibits them
47
describe lithium's effects on the kidney
lithium enters prinicpal cells of collecting duct --> accumulation of lithium in these cells --> resistance to ADH --> polyuria and polydipsia
48
patient presenting with nephrogenic diabetes insipidus with a mood disorder was most likely prescribed:
lithium
49
drug interactions with lithium
- diuretics (thiazides) - ACEIs (lisinopril) - NSAIDs
50
side effects of lithium
- polyuria/polydipsia - tremors - mental confusion/dizziness/sedation - thyroid goiter - leukocytosis - seizures/serotonin syndrome
51
indications for lithium
- acute and maintenance tx of mania/bipolar I | - augmentation in unipolar depressive pts
52
indications for valproic acid/divalproex
acute bipolar I
53
indications for lamotrigine
maintenance of bipolar disorder I and II
54
indications for carbamazepine
acute and maintenance tx of acute mania and mixed episodes (bipolar I)
55
which mood stabilizer is a major CYP450 inducer
carbamazepine